Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-67

…don’t want to, or do understand but continue to deliberately create negative sentiment for personal motive…

yes @bid some are BORING deliberately trying to confuse like every day of the week since January ASX SPL release on study


Seeing Australia restricts antivirals to PAX & Lagevrio and to over 70s and some limited medical criteria - 80% of the popn has ZERO access to antivirals unless Hospitalised. Access to VIRALEZE for the statistically significant over 45yrs would give 10.6 million or 42% of Australians access to PROVEN (statistically significant) treatment
and another 43% of the popn between 12yrs and 45yrs could be offered Viraleze on the basis that it is safe and treats covid even if not significantly better than the placebo in that cohort who mostly got over covid in less than 7 days of